A Signature Based on Costimulatory Molecules for the Assessment of Prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma.
Chen B, Yao Y, Mao D, Li C, Wang X, Sheng S, Zhang L, Wang X, Chen S, Xu W, Deng J, Sun C, Zhou Q, Lowe S, Bentley R, Shao W, Li H.
Chen B, et al. Among authors: li c, li h.
Front Immunol. 2022 Jul 22;13:928742. doi: 10.3389/fimmu.2022.928742. eCollection 2022.
Front Immunol. 2022.
PMID: 35935979
Free PMC article.